Clinical Mass Spectrometry Market

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

Clinical Mass Spectrometry Market contains market size and forecasts of Clinical Mass Spectrometry in global, including the following market information:

Global Clinical Mass Spectrometry Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Clinical Mass Spectrometry Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Clinical Mass Spectrometry companies in 2021 (%)

The global Clinical Mass Spectrometry market was valued at 857.3 million in 2021 and is projected to reach US$ 1625.5 million by 2028, at a CAGR of 9.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

LC-MS-MS Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Clinical Mass Spectrometry include AB Sciex (Danaher), Bruker, Thermo Fisher, Agilent, Waters, Perkin Elmer and Shidmazu, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Mass Spectrometry manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clinical Mass Spectrometry Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Clinical Mass Spectrometry Market Segment Percentages, by Type, 2021 (%)

LC-MS-MS

MALDI-TOF

Others

Global Clinical Mass Spectrometry Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Clinical Mass Spectrometry Market Segment Percentages, by Application, 2021 (%)

Clinical Diagnostics

Clinical Research

Global Clinical Mass Spectrometry Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Clinical Mass Spectrometry Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Clinical Mass Spectrometry revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Clinical Mass Spectrometry revenues share in global market, 2021 (%)

Key companies Clinical Mass Spectrometry sales in global market, 2017-2022 (Estimated), (Units)

Key companies Clinical Mass Spectrometry sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AB Sciex (Danaher)

Bruker

Thermo Fisher

Agilent

Waters

Perkin Elmer

Shidmazu